These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3965513)

  • 1. Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site.
    Usharani P; Warn-Cramer BJ; Kasper CK; Bajaj SP
    J Clin Invest; 1985 Jan; 75(1):76-83. PubMed ID: 3965513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteins.
    Spitzer SG; Warn-Cramer BJ; Kasper CK; Bajaj SP
    Biochem J; 1990 Jan; 265(1):219-25. PubMed ID: 2105717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental and theoretical evidence supporting the role of Gly363 in blood coagulation factor IXa (Gly193 in chymotrypsin) for proper activation of the proenzyme.
    Bajaj SP; Spitzer SG; Welsh WJ; Warn-Cramer BJ; Kasper CK; Birktoft JJ
    J Biol Chem; 1990 Feb; 265(5):2956-61. PubMed ID: 2303434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in hemophilia Bm occur at the Arg180-Val activation site or in the catalytic domain of factor IX.
    Bertina RM; van der Linden IK; Mannucci PM; Reinalda-Poot HH; Cupers R; Poort SR; Reitsma PH
    J Biol Chem; 1990 Jul; 265(19):10876-83. PubMed ID: 2162822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular defect in factor IX Tokyo: substitution of valine-182 by alanine at position P2' in the second cleavage site by factor XIa resulting in impaired activation.
    Maekawa H; Sugo T; Yamashita N; Kamiya K; Umeyama H; Miura N; Naka H; Nishimura T; Yoshioka A; Matsuda M
    Biochemistry; 1993 Jun; 32(24):6146-51. PubMed ID: 8512923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the catalytic domain of factor IX that are related to the subclass hemophilia Bm.
    Hamaguchi N; Roberts H; Stafford DW
    Biochemistry; 1993 Jun; 32(25):6324-9. PubMed ID: 8518277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor IX Deventer-evidence for the heterogeneity of hemophilia BM.
    Bertina RM; van der Linden IK
    Thromb Haemost; 1982 Apr; 47(2):136-40. PubMed ID: 7101232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of factor IX: defects in haemophilia B.
    McGraw RA; Davis LM; Lundblad RL; Stafford DW; Roberts HR
    Clin Haematol; 1985 Jun; 14(2):359-83. PubMed ID: 3899439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The abnormal factor IX of hemophilia B+ variants.
    Bertina RM; Veltkamp JJ
    Thromb Haemost; 1978 Oct; 40(2):335-49. PubMed ID: 734633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional consequences of an arginine180 to glutamine mutation in factor IX Hilo.
    Monroe DM; McCord DM; Huang MN; High KA; Lundblad RL; Kasper CK; Roberts HR
    Blood; 1989 May; 73(6):1540-4. PubMed ID: 2713493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of factor IX BM. Difference of cleavage sites by factor XIa and Ca2+ in factor IX Kashihara, factor IX Nagoya and factor IX Niigata.
    Yoshioka A; Ohkubo Y; Nishimura T; Tanaka I; Fukui H; Ogata K; Kamiya T; Takahashi H
    Thromb Res; 1986 Jun; 42(5):595-604. PubMed ID: 3487139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular defect in factor IXBm Lake Elsinore. Substitution of Ala390 by Val in the catalytic domain.
    Spitzer SG; Pendurthi UR; Kasper CK; Bajaj SP
    J Biol Chem; 1988 Aug; 263(22):10545-8. PubMed ID: 3392024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX.
    Ludwig M; Sabharwal AK; Brackmann HH; Olek K; Smith KJ; Birktoft JJ; Bajaj SP
    Blood; 1992 Mar; 79(5):1225-32. PubMed ID: 1346975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa.
    Braunstein KM; Noyes CM; Griffith MJ; Lundblad RL; Roberts HR
    J Clin Invest; 1981 Dec; 68(6):1420-6. PubMed ID: 6976355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a factor IX variant with a glycine207 to glutamic acid mutation.
    Lin SW; Lin CN; Hamaguchi N; Smith KJ; Shen MC
    Blood; 1994 Sep; 84(6):1866-73. PubMed ID: 7915915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4).
    Hamaguchi M; Matsushita T; Tanimoto M; Takahashi I; Yamamoto K; Sugiura I; Takamatsu J; Ogata K; Kamiya T; Saito H
    Thromb Haemost; 1991 May; 65(5):514-20. PubMed ID: 1871712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VII activity and antigen in haemophilia B variants.
    Mazzucconi MG; Bertina RM; Romoli D; Orlando M; Avvisati G; Mariani G
    Thromb Haemost; 1980 Feb; 43(1):16-9. PubMed ID: 7404475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human factor VII in the initiation of tissue factor-dependent coagulation.
    Rao LV; Rapaport SI; Bajaj SP
    Blood; 1986 Sep; 68(3):685-91. PubMed ID: 3488776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa.
    Jones ME; Griffith MJ; Monroe DM; Roberts HR; Lentz BR
    Biochemistry; 1985 Dec; 24(27):8064-9. PubMed ID: 3879187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.